Form D · Other Health Care

Rediscovery Life Sciences AKI LLC

Charleston, SC · CIK 0001681048

Offering snapshot reported Apr 11, 2023 · SEC filing

Reported sold
$450K
Offering amount: $900K
Investors reported
22
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 27, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 11, 2023Initial$449,983No comparison22SEC filing
May 7, 2020Initial$3,799,981No comparison17SEC filing
Aug 5, 2016Initial$750,000No comparison9SEC filing

Offering details

Securities
Equity, Option to acquire, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-478495
Series B Preferred Units consisting of Series B Preferred Stock and Common Stock Unit Purchase Warrants.

Source: Form D, filed Apr 11, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Adair Director
Sunil Desai Director
Patrick K. Donnelly Director
Mark Hackett Director
Rick Schnellman Director
Rick Schnellmann Director, Executive
Richard Shea Director, Executive
Anita Watkins Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
8 Church Street
Charleston, SC, 29401